ScreenPoint Medical has announced that its Transpara breast AI has surpassed 5 million mammograms, including over 1 million Tomosynthesis (3D) exams analyzed in support of radiologists reading mammography exams. The company will showcase its Transpara results at the upcoming 109th Annual Radiological Society of North America (RSNA) meeting, RSNA 2023, November 26-30, at McCormick Place in Chicago, IL.
ScreenPoint Medical Showcases Global Momentum for Transpara(R) Breast AI at EUSOBI finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Combining artificial intelligence (AI) systems for short- and long-term breast cancer risk results in an improved cancer risk assessment, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA).
According to a new study published in Radiology, AI systems for short- and long-term breast cancer risk could result in an improved cancer risk assessment.